Ferulic acid, but not tetramethylpyrazine, significantly attenuates retinal ischemia/reperfusion-induced alterations by acting as a hydroxyl radical scavenger

Hsiao Ming Chao, De Ean Lin, Ying Chang, Wen-Ming Hsu, Shui Mei Lee, Fenq Lih Lee, Chin Wen Chi, Wynn H.T. Pan, Tsung Yun Liu, Wing Yiu Lui, Low Tone Ho, Cheng Deng Kuo, Chia Chin Chan, Fang Ping Chao

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Purpose: Ischemia plays an important role in glaucomatous optic neuropathy and retinal vascular occlusive disorders, which renders investigation vital. Methods: Retinal ischemia was induced by raising intraocular pressure to 120 mmHg. Its mechanism and management was evaluated by measuring .OH levels, electroretinogram (ERG) b-wave amplitudes, immunohisto-chemistry, and reverse transcriptase polymerase chain reaction. Results: Ischemia for 45, 60, and 75 min caused significant and time-dependent increased .OH levels, which might contribute to retinal ischemic injures. Specifically, 60 min of ischemia plus reperfusion, causing moderate oxidative stress, resulted in retinal changes that were characterized by decreased ERG b-wave amplitudes, loss of choline acetyltransferase immunolabeled amacrine cell bodies/neuronal processes, downregulated Thy-1 m-RNA levels (indexing retinal ganglion cells; RGCs), and reduced thickness of the Thy-1 immunolabeled RGC and inner plexiform layers. Of clinical importance, this is the first study to show that ischemic detrimental effects are significantly blunted when 0.5 nmol of ferulic acid, one active ingredient of Ligusticum walliichi (Chuanxiong), was applied 24 h before retinal ischemia. Further, but not to a significant level, 0.5 nmole of tetramethylpyazine, another Chuanxiong-active component, showed such an ameliorating trend. Moreover, the 60-min ischemia-induced significant increase in .OH production was significantly attenuated by FA. Conclusions: FA is able to protect against retinal ischemia and possibly glaucoma by, at least in part, acting as a .OH scavenger.

Original languageEnglish
Pages (from-to)461-472
Number of pages12
JournalJournal of Ocular Pharmacology and Therapeutics
Volume24
Issue number5
DOIs
Publication statusPublished - Oct 1 2008

Fingerprint

ferulic acid
Hydroxyl Radical
Reperfusion
Ischemia
Ligusticum
Amacrine Cells
Retinal Vessels
Optic Nerve Diseases
Choline O-Acetyltransferase
Retinal Ganglion Cells
tetramethylpyrazine
Reverse Transcriptase Polymerase Chain Reaction
Intraocular Pressure
Glaucoma

ASJC Scopus subject areas

  • Ophthalmology
  • Pharmacology
  • Pharmacology (medical)

Cite this

Ferulic acid, but not tetramethylpyrazine, significantly attenuates retinal ischemia/reperfusion-induced alterations by acting as a hydroxyl radical scavenger. / Chao, Hsiao Ming; Lin, De Ean; Chang, Ying; Hsu, Wen-Ming; Lee, Shui Mei; Lee, Fenq Lih; Chi, Chin Wen; Pan, Wynn H.T.; Liu, Tsung Yun; Lui, Wing Yiu; Ho, Low Tone; Kuo, Cheng Deng; Chan, Chia Chin; Chao, Fang Ping.

In: Journal of Ocular Pharmacology and Therapeutics, Vol. 24, No. 5, 01.10.2008, p. 461-472.

Research output: Contribution to journalArticle

Chao, Hsiao Ming ; Lin, De Ean ; Chang, Ying ; Hsu, Wen-Ming ; Lee, Shui Mei ; Lee, Fenq Lih ; Chi, Chin Wen ; Pan, Wynn H.T. ; Liu, Tsung Yun ; Lui, Wing Yiu ; Ho, Low Tone ; Kuo, Cheng Deng ; Chan, Chia Chin ; Chao, Fang Ping. / Ferulic acid, but not tetramethylpyrazine, significantly attenuates retinal ischemia/reperfusion-induced alterations by acting as a hydroxyl radical scavenger. In: Journal of Ocular Pharmacology and Therapeutics. 2008 ; Vol. 24, No. 5. pp. 461-472.
@article{fe892aa535ea4c32aad8488318e2daba,
title = "Ferulic acid, but not tetramethylpyrazine, significantly attenuates retinal ischemia/reperfusion-induced alterations by acting as a hydroxyl radical scavenger",
abstract = "Purpose: Ischemia plays an important role in glaucomatous optic neuropathy and retinal vascular occlusive disorders, which renders investigation vital. Methods: Retinal ischemia was induced by raising intraocular pressure to 120 mmHg. Its mechanism and management was evaluated by measuring .OH levels, electroretinogram (ERG) b-wave amplitudes, immunohisto-chemistry, and reverse transcriptase polymerase chain reaction. Results: Ischemia for 45, 60, and 75 min caused significant and time-dependent increased .OH levels, which might contribute to retinal ischemic injures. Specifically, 60 min of ischemia plus reperfusion, causing moderate oxidative stress, resulted in retinal changes that were characterized by decreased ERG b-wave amplitudes, loss of choline acetyltransferase immunolabeled amacrine cell bodies/neuronal processes, downregulated Thy-1 m-RNA levels (indexing retinal ganglion cells; RGCs), and reduced thickness of the Thy-1 immunolabeled RGC and inner plexiform layers. Of clinical importance, this is the first study to show that ischemic detrimental effects are significantly blunted when 0.5 nmol of ferulic acid, one active ingredient of Ligusticum walliichi (Chuanxiong), was applied 24 h before retinal ischemia. Further, but not to a significant level, 0.5 nmole of tetramethylpyazine, another Chuanxiong-active component, showed such an ameliorating trend. Moreover, the 60-min ischemia-induced significant increase in .OH production was significantly attenuated by FA. Conclusions: FA is able to protect against retinal ischemia and possibly glaucoma by, at least in part, acting as a .OH scavenger.",
author = "Chao, {Hsiao Ming} and Lin, {De Ean} and Ying Chang and Wen-Ming Hsu and Lee, {Shui Mei} and Lee, {Fenq Lih} and Chi, {Chin Wen} and Pan, {Wynn H.T.} and Liu, {Tsung Yun} and Lui, {Wing Yiu} and Ho, {Low Tone} and Kuo, {Cheng Deng} and Chan, {Chia Chin} and Chao, {Fang Ping}",
year = "2008",
month = "10",
day = "1",
doi = "10.1089/jop.2008.0005",
language = "English",
volume = "24",
pages = "461--472",
journal = "Journal of Ocular Pharmacology and Therapeutics",
issn = "1080-7683",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

TY - JOUR

T1 - Ferulic acid, but not tetramethylpyrazine, significantly attenuates retinal ischemia/reperfusion-induced alterations by acting as a hydroxyl radical scavenger

AU - Chao, Hsiao Ming

AU - Lin, De Ean

AU - Chang, Ying

AU - Hsu, Wen-Ming

AU - Lee, Shui Mei

AU - Lee, Fenq Lih

AU - Chi, Chin Wen

AU - Pan, Wynn H.T.

AU - Liu, Tsung Yun

AU - Lui, Wing Yiu

AU - Ho, Low Tone

AU - Kuo, Cheng Deng

AU - Chan, Chia Chin

AU - Chao, Fang Ping

PY - 2008/10/1

Y1 - 2008/10/1

N2 - Purpose: Ischemia plays an important role in glaucomatous optic neuropathy and retinal vascular occlusive disorders, which renders investigation vital. Methods: Retinal ischemia was induced by raising intraocular pressure to 120 mmHg. Its mechanism and management was evaluated by measuring .OH levels, electroretinogram (ERG) b-wave amplitudes, immunohisto-chemistry, and reverse transcriptase polymerase chain reaction. Results: Ischemia for 45, 60, and 75 min caused significant and time-dependent increased .OH levels, which might contribute to retinal ischemic injures. Specifically, 60 min of ischemia plus reperfusion, causing moderate oxidative stress, resulted in retinal changes that were characterized by decreased ERG b-wave amplitudes, loss of choline acetyltransferase immunolabeled amacrine cell bodies/neuronal processes, downregulated Thy-1 m-RNA levels (indexing retinal ganglion cells; RGCs), and reduced thickness of the Thy-1 immunolabeled RGC and inner plexiform layers. Of clinical importance, this is the first study to show that ischemic detrimental effects are significantly blunted when 0.5 nmol of ferulic acid, one active ingredient of Ligusticum walliichi (Chuanxiong), was applied 24 h before retinal ischemia. Further, but not to a significant level, 0.5 nmole of tetramethylpyazine, another Chuanxiong-active component, showed such an ameliorating trend. Moreover, the 60-min ischemia-induced significant increase in .OH production was significantly attenuated by FA. Conclusions: FA is able to protect against retinal ischemia and possibly glaucoma by, at least in part, acting as a .OH scavenger.

AB - Purpose: Ischemia plays an important role in glaucomatous optic neuropathy and retinal vascular occlusive disorders, which renders investigation vital. Methods: Retinal ischemia was induced by raising intraocular pressure to 120 mmHg. Its mechanism and management was evaluated by measuring .OH levels, electroretinogram (ERG) b-wave amplitudes, immunohisto-chemistry, and reverse transcriptase polymerase chain reaction. Results: Ischemia for 45, 60, and 75 min caused significant and time-dependent increased .OH levels, which might contribute to retinal ischemic injures. Specifically, 60 min of ischemia plus reperfusion, causing moderate oxidative stress, resulted in retinal changes that were characterized by decreased ERG b-wave amplitudes, loss of choline acetyltransferase immunolabeled amacrine cell bodies/neuronal processes, downregulated Thy-1 m-RNA levels (indexing retinal ganglion cells; RGCs), and reduced thickness of the Thy-1 immunolabeled RGC and inner plexiform layers. Of clinical importance, this is the first study to show that ischemic detrimental effects are significantly blunted when 0.5 nmol of ferulic acid, one active ingredient of Ligusticum walliichi (Chuanxiong), was applied 24 h before retinal ischemia. Further, but not to a significant level, 0.5 nmole of tetramethylpyazine, another Chuanxiong-active component, showed such an ameliorating trend. Moreover, the 60-min ischemia-induced significant increase in .OH production was significantly attenuated by FA. Conclusions: FA is able to protect against retinal ischemia and possibly glaucoma by, at least in part, acting as a .OH scavenger.

UR - http://www.scopus.com/inward/record.url?scp=52449116009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52449116009&partnerID=8YFLogxK

U2 - 10.1089/jop.2008.0005

DO - 10.1089/jop.2008.0005

M3 - Article

C2 - 18788996

AN - SCOPUS:52449116009

VL - 24

SP - 461

EP - 472

JO - Journal of Ocular Pharmacology and Therapeutics

JF - Journal of Ocular Pharmacology and Therapeutics

SN - 1080-7683

IS - 5

ER -